Dr. Christine Power graduated from the University of Leeds, UK, with a BSc. Honours degree in Biochemistry, followed by a Ph.D. from the University of Surrey, UK. She has worked in the pharmaceutical and biotech industries in various roles of increasing responsibility in R&D for over 25 years starting at Ciba-Geigy (now Novartis in Switzerland), British Biotechnology Ltd, UK; Glaxo Institute for Molecular Biology (Geneva, Switzerland), Serono and later Merck Serono (part Merck KGaA), Arsanis Biosciences (Vienna, Austria) and most recently for GSK (Stevenage, UK). She has experience working in a variety of therapeutic areas including allergy and asthma, cardiovascular, autoimmune and inflammatory diseases, cancer and infectious diseases. She has broad expertise in the discovery and pre-clinical development of therapeutic proteins and monoclonal antibodies. Whilst working at Serono, Merck Serono and GSK she successfully managed a number of scientific collaborations and funded research projects with pharmaceutical and biotech companies (including start-ups) and academia, and worked with their respective business development units performing due diligence and evaluation of in-licensing opportunities for therapeutic proteins and antibodies as well as for new technologies. Dr. Power has an excellent track record of innovation and productivity in research witnessed by inventorship on over 40 patent applications, and is author of over 80 scientific papers. With this expert background, in 2020, Dr. Power created her own company, Christine Power Consulting based in France, to provide strategic advice and scientific opinion to biotech and pharmaceutical companies, start-ups, and universities in the field of antibody discovery and development.
You are here: / Christine Power, PhD